Journals / Medicine Science / 2019 / Cilt: 8 - Sayı: 4

Relationship between osteocalcin levels and gestational diabetes mellitus

Pages
1011–1016
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results suggest that osteocalcin may play a role in gestational diabetes mellitus especially if pregnant women are older, multiparous, and obese.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteocalcin is an osteoblast-derived protein mainly acting on bone formation.
📊
Key Findings & Data:We performed a case–control cross sectional study and evaluated all the demographic and anthropometric parameters of 80 pregnant women whose age and body mass indices similar, half of them having normal glucose tolerance (NGT) and the other half having gestational diabetes mellitus (GDM).
💡
Conclusion & Impact:Our results suggest that osteocalcin may play a role in gestational diabetes mellitus especially if pregnant women are older, multiparous, and obese.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Osteocalcin is an osteoblast-derived protein mainly acting on bone formation. There is growing evidence that osteocalcin has an important role in glucose metabolism. It was not fully elucidated in gestational diabetes mellitus. The aim of our study was to investigate osteocalcin levels in gestational diabetes mellitus and its subgroups. We performed a case–control cross sectional study and evaluated all the demographic and anthropometric parameters of 80 pregnant women whose age and body mass indices similar, half of them having normal glucose tolerance (NGT) and the other half having gestational diabetes mellitus (GDM). We compared osteocalcin, calcium metabolism parameters, glucose, lipid levels, insulin resistance parameters, and investigated correlations of all parameters in NGT and GDM. We also analyzed GDM subgroups, which were classified according to age, parity, body mass index (BMI), and vitamin D levels. Osteocalcin levels were increased in patients with GDM and in older, multiparous, with low vitamin D or high body mass index GDM subgroups but these increases were not statistically significant (P>0.05). There was a positive correlation between osteocalcin and C peptide in GDM group and also in GDM subgroups with age≥30, multiparous, vitamin D≥20 ng/ml or BMI≥30 kg/m2 (r=0.424, P=0.006; r=0.460, P=0.011; r=0.408, P=0.017; r=0.520, P=0.013; r=0.603, P=0.002 respectively). We also found a negative correlation between Osteocalcin and HDLcholesterol in GDM and in multiparous, vitamin D≥20 ng/ml or BMI<30 kg/m2 GDM subgroups (r=-0.334, P=0.035; r=-0.352, P=0.041; r=-0.430, P=0.041; r=-0.442, P=0.031 respectively). Our results suggest that osteocalcin may play a role in gestational diabetes mellitus especially if pregnant women are older, multiparous, and obese.

🔖

Cite This Article

KOC, G. V., GÜRSOY, G., COPUR, B. H., EKSİLER, H. C., YİLDİRİM, A., GORAR, S., CULHA, C., ARAL, Y. (2019). Relationship between osteocalcin levels and gestational diabetes mellitus. Medicine Science, Cilt: 8 - Sayı: 4, 1011–1016. https://ajindex.com/articles/277598

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Rosen CJ, Donahau LR, Hunter SJ. Insulin like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med. 1994; 206:83-102.
  2. Hinoi E, Karsenty G. Reciprocal regulation of bone and energy metabolism. J Muskuloskelet Neuronal Interact. 2008;8:351-3.
  3. Mizokami A, Yasutake Y, Gao J, et al. Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. PLoS One. 2013;8:e57375. Mizokami A, Yasutake Y, Higashi S, et al. Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion. Bone. 2014;69 C:68–79.
  4. Akin O, Göl K, Aktürk M, et al. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol. 2003;17:19-29.
  5. Pater A, Sypniewska G, Pileki O. Biochemical markers of bone activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2010;23:81-6.
  6. Winhofer Y, Handisurya A, Tura A, et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care. 2010;1:13943. 8.Saucedo R, Rico G, Vega G, et al. Osteocalcin, under-carboxylated osteocalcin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women. J Endocrinol Invest. 2015;38:519-26.
  7. Yoon BK, Lee J, Choi D, et al. Changes in biochemical bone markers during pregnancy and puerperium. J Korean Med Sci. 2000;15:189-93. 10. Tabatabaei N, Giguère Y, Forest JC, et al. Osteocalcin is higher across pregnancy in Caucasian women with gestational diabetes mellitus. Can J Diabetes. 2014;38:307-13. 11. Telejko B, Kalejta K, Kuzmicki M, et al. The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. Ann Agric Environ Med. 2015;22:307- 12. 12. Martinez ME, Catalan P, Lisbona A, et al. Serum osteocalcin concentrations in diabetic pregnant women and their newborns. Horm Metab Res. 1994;26:338-42. 13. Metzger BE, Gabbe SG, Persson B. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:67682. 14. Bilotta FL, Arcidiacono B, Messineo S, et al. Insulin and osteocalcin: further evidence for a mutual cross-talk. Endocrine. 2018;59:622-32. 15. Ng KW,